ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing.
Consult your healthcare professional to see if this product is right for you.

Dexcom G7 is here!

Powerfully Simple Glucose Monitoring

Better Accuracy** & Health Outcomes1-5
† Display devices sold separately.
  • Learn about Dexcom G7
t:slim X2 insulin pump and Dexcom G7 sensor

You can now connect your t:slim X2 insulin pump with Dexcom G7 with new
Control-IQ update!

What is Continuous Glucose Monitoring (CGM)?

CGM is a glucose management tool that measures glucose levels 24 hours a day using a sensor inserted just under the skin. The wearable sends glucose readings to a compatible device such as phone or an optional Receiver. It provides you with real-time glucose readings and can also alert you when your levels are too high or drop too low.
*If your glucose alerts and readings from the G6 or G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Display devices sold separately. For a list of compatible smart devices, please visit
www.dexcom.com/compatibility.
  • Learn about CGM

Powerfully Simple Glucose Monitoring

Minimal Training, Maximum Benefits, making it a valuable addition to your glucose management. Dexcom G7 is now easier than ever to use and seamlessly integrates into your daily routine.

Superior Accuracy**

Dexcom G7 is our most accurate CGM system5 giving you the confidence to make informed treatment decisions.^^

Better Health Outcomes

High & Low Protection††
Dexcom G7 can help avoid lows (with Urgent Low Soon alert) and rebound highs, enabling immediate action.#,6

Looking for information on accessing subsidised CGM?

Dexcom G7 has officially launched in Australia and is available on our online store currently.
The Dexcom G7 is currently not subsidised under the National Diabetes Service Scheme (NDSS)^ for people living with Type 1 diabetes. We are however working alongside the government to add Dexcom G7 into the existing subsidy initiative. As soon as we have more information, we’ll let you know.
In the meantime, the Dexcom G6 is currently subsidised for Australians living with type 1 diabetes through the NDSS.
† Display devices sold separately. § Dexcom G7 sensors are waterproof and may be submerged under 2.4 meters. Dexcom receivers are not waterproof or water resistant.

Loved by real Dexcom users

Dexcom has had a hugely positive contribution towards managing my sugar levels, and subsequent health. My favourite feature of Dexcom CGM is the way it communicates with my phone and my smart watch# in telling me how my sugar levels are trending.
Lara, Dexcom Warrior 
  • Check out her story
Being able to share the data with my wife via Dexcom Share has eased her previous concerns, as she knows that I can keep on top of my glucose levels and take action to rectify changes before they become an issue, particularly when I’m running solo and in a remote location.
Pete, Dexcom Warrior
en-au

Continuous readings & learnings

Check out popular articles from the CGM blog that breaks down complex topics.

We're here for you

Frequently Asked Questions

Still have questions? Click below to visit our FAQ page.

Contact us

Call our 24/7 technical support line and we will do our best to assist you.

Useful Resources

Find all our helpful resources like brochures and flyers.
References:
† Display devices sold separately. Tor a list of compatible smart devices, please visit
www.dexcom.com/compatibility.
‡ A touch screen receiver can be acquired as an optional display device.
^Eligibility criteria applies. Visit
ndss.com.au/cgm for more details.
^^ This product is indicated for persons with diabetes mellitus age 2 years and older where SMBG is indicated
** As compared to Dexcom G6 System.
†† As compared to SMBG.
# Results obtained with a prior generation Dexcom CGM system with same Urgent Low Soon alert.
§ Dexcom G7 sensors are waterproof and may be submerged under 2.4 meters. Dexcom receivers are not waterproof or water resistant.
1. Beck RW, et al. JAMA. 2017;317(4):371-378. 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3. Martens T, et al. JAMA. 2021;325(22):2262-2272.4. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 5. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7​. 6. Acciaroli G, et al. J Diabetes Sci Technol. 2022;16(3):677-82.
Privacy PolicyTerms of UseSafety InformationTrust CenterCompatibilityDownloads and GuidesCareers

MAT-4989

© 2024 Dexcom, Inc. All rights reserved.

AU flag

AU

Change region